Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
Cancer Science
|
May 9, 2019
Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression
Xuan Yang, Bi-Si Miao, Chuan-Yuan Wei, et al.
Cancer Cell International
|
March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
Zheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
BMC Medicine
|
October 22, 2025
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study
Xiao-Yong Huang, Guo-Ming Shi, Zhi-Tao Zheng, et al.
Journal of Hematology & Oncology
|
November 28, 2021
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
Jia-Cheng Lu, Peng-Fei Zhang, Xiao-Yong Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition
Kai Zhu, Zhi Dai, Qi Pan, et al.
Plos One
|
March 20, 2012
Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection
Xiao-Yong Huang, Guo-Ming Shi, Ranjan Prasad Devbhandari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery
Xin-Rong Yang, Yang Xu, Bin Yu, et al.
Journal of Cancer
|
November 28, 2019
Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma
Li-Xin Liu, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Journal of Clinical Pathology
|
January 19, 2017
Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro
Qiang Kang, Jia-Bin Cai, Rui-Zhao Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection
Xin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
Cancer Science
|
May 9, 2019
Lymphoid-specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression
Xuan Yang, Bi-Si Miao, Chuan-Yuan Wei, et al.
Cancer Cell International
|
March 20, 2022
KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma
Zheng Gao, Jia-Feng Chen, Xiao-Gang Li, et al.
BMC Medicine
|
October 22, 2025
Anti-PD1 antibody toripalimab combined with lenvatinib, or GEMOX chemotherapy combined with lenvatinib as first-line therapy in patients with advanced intrahepatic cholangiocarcinoma: a randomized, open, two-cohort Phase 2 Study
Xiao-Yong Huang, Guo-Ming Shi, Zhi-Tao Zheng, et al.
Journal of Hematology & Oncology
|
November 28, 2021
Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
Jia-Cheng Lu, Peng-Fei Zhang, Xiao-Yong Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition
Kai Zhu, Zhi Dai, Qi Pan, et al.
Plos One
|
March 20, 2012
Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection
Xiao-Yong Huang, Guo-Ming Shi, Ranjan Prasad Devbhandari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 27, 2009
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery
Xin-Rong Yang, Yang Xu, Bin Yu, et al.
Journal of Cancer
|
November 28, 2019
Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma
Li-Xin Liu, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Journal of Clinical Pathology
|
January 19, 2017
Mortalin promotes cell proliferation and epithelial mesenchymal transition of intrahepatic cholangiocarcinoma cells in vitro
Qiang Kang, Jia-Bin Cai, Rui-Zhao Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2008
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection
Xin-Rong Yang, Yang Xu, Guo-Ming Shi, et al.
Page
of 10